Trial intelligence / Profile preview

Efficacy and Safety of Olmesartan in Elderly Patients With Mild to Moderate Hypertension

2004-001616-31Phase 3Completed

Sponsor
Istituto Lusofarmaco
Start
Sep 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of olmesartan in essential hypertension (2 arms), sponsored by Istituto Lusofarmaco. Started Sep 2004; status: completed.

02

Drugs

olmesartan
03

Conditions

essential hypertension

Beyond the preview

Go deeper on 2004-001616-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001616-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call